Comprehensive treatment of malignant hematological diseases: standardized and individualized combined chemotherapy and hematopoietic stem cell transplantation are carried out to treat all kinds of malignant hematological diseases, so that the treatment of myelodysplastic syndromes such as leukemia, lymphoma and myeloma can reach the domestic advanced level.

Treatment of hematological diseases with combination of traditional Chinese and western medicine: Optimizing the application of combination of traditional Chinese and western medicine to treat all kinds of hematological diseases, especially the treatment of cytopenia and allergic purpura, has achieved good results.

Standardized treatment of acute leukemia in children: This department is the designated treatment specialty of funds such as "Shenhua Love Fund" and "Jackie Chan Fund", which effectively reduces the treatment burden of leukemia in children, and has specially set up a "love ward" for hematological diseases in children, standardizing the standard treatment technology of acute leukemia in children, so that the curative effect of leukemia in children, especially acute lymphoblastic leukemia in children, has reached the domestic advanced level.

Hematopoietic stem cell transplantation: This department is the earliest specialist in carrying out hematopoietic stem cell transplantation in China, and has become the largest and most advanced clinical stem cell transplantation treatment center in northwest China. He has rich experience in the treatment of malignant hematological diseases and severe aplastic anemia, such as autologous hematopoietic stem cell transplantation, allogeneic hematopoietic stem cell transplantation (matched or semi-matched, related or unrelated, umbilical cord blood, etc.), and mixed hematopoietic stem cell transplantation. There are more than 5 cases of transplantation every year, and the treatment of transplantation technology has reached the leading level in China. And in the aspect of stem cell therapy for various intractable diseases, mesenchymal stem cells have been developed to treat cerebral palsy, motor neuron disease and multiple sclerosis in children. Hematopoietic stem cells treat severe hepatitis, liver cirrhosis, diabetic foot, etc. CD34 stem cells have achieved remarkable results in the treatment of traumatic brain injury, nerve injury and osteochondral injury.

Consultation Center for Diagnosis of Difficult Hematological Diseases: The Hematological Center has complete equipment for diagnosis of hematological diseases. It is the first unit in northwest China to carry out typing diagnosis and gene matching of leukemia by flow cytometry. Now it can independently carry out HLA transplantation matching, diagnosis of leukemia morphology, cytogenetics, immunology and molecular biology, detection of fusion oncogenes FISH and PCR for hematological diseases, detection of minimal residual disease of leukemia, detection of bleeding function, etc. Under the careful consultation of experts in clinical hematology and experimental hematology, the level of disease analysis and diagnosis has been continuously improved, and more than 2 difficult hematological diseases in and out of the province have been diagnosed every year, which provides a guarantee for correct diagnosis and treatment.

the only national stem cell treatment center in northwest China-the stem cell treatment center of Lanzhou General Hospital of Lanzhou Military Region was formally established. It is understood that the center was approved by the Ministry of Health of the Military Region and established on the basis of the Department of Hematology of Lanzhou Military Region General Hospital, one of the two hematology centers in the whole army, the largest hematology treatment center in Gansu Province and a member unit of the hematopoietic stem cell transplantation group of the National Hematology Society.

In order to further promote the development of research and application of stem cell and tumor biotherapy in our province, and to explore the application technology of stem cell transplantation in treating various tissue injury diseases and tumor biotherapy, with the approval of the Continuing Education Committee of Gansu Provincial Health Department and the Ministry of Health of Lanzhou Military Region, the "Regenerative Medicine-New Progress in Stem Cell Research and New Progress in Gene, Stem Cell and Biotherapy and the Inauguration Ceremony of the Stem Cell Therapy Center of Lanzhou Military Region General Hospital" hosted by Lanzhou Military Region General Hospital was held on the same day.